Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention

Lignende værker

• Reply to Wang et al.: Tocilizumab treatment should be used in a timely manner, at suitable dose, and in suitable patients
  af: Xu, Xiaoling, et al.
  Udgivet: (2020)
• Effective treatment of severe COVID-19 patients with tocilizumab
  af: Xu, Xiaoling, et al.
  Udgivet: (2020)
• Why tocilizumab could be an effective treatment for severe COVID-19?
  af: Fu, Binqing, et al.
  Udgivet: (2020)
• Reply to Yang et al
  af: Dionne-Odom, Jodie, et al.
  Udgivet: (2013)
• Reply to Yang et al
  af: Ganesan, Anuradha, et al.
  Udgivet: (2015)